National Center for Advancing Translational Sciences; Notice of Meeting, 76206-76207 [2022-26992]

Download as PDF 76206 Federal Register / Vol. 87, No. 238 / Tuesday, December 13, 2022 / Notices meeting, the material will be made publicly available on ONC’s website after the meeting, at www.healthit.gov/ hitac. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person prior to the meeting date. An oral public comment period will be scheduled at each meeting. Time allotted for each commenter will be limited to three minutes. If the number of speakers requesting to comment is greater than can be reasonably accommodated during the scheduled public comment period, ONC will take written comments after the meeting. All HITAC meetings in 2023 will be virtual until further notice. Please refer to future Federal Register Notices for updated information on in-person meetings. ONC welcomes the attendance of the public at its HITAC meetings. If you require special accommodations due to a disability, please contact Michael Berry at least seven (7) days in advance of the meeting. Notice of these meetings are given under the Federal Advisory Committee Act (Pub. L. 92–463, 5 U.S.C., app. 2). Dated: December 8, 202. Michael Berry, Designated Federal Officer, Office of the National Coordinator for Health Information Technology. [FR Doc. 2022–27009 Filed 12–12–22; 8:45 am] BILLING CODE 4150–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [Document Identifier: OS–0990–New] Agency Information Collection Request; 60-Day Public Comment Request Office of the Secretary, HHS. Notice. AGENCY: ACTION: In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. DATES: Comments on the ICR must be received on or before February 13, 2023. ADDRESSES: Submit your comments to Sherrette.Funn@hhs.gov; PRA@hhs.gov, or by calling (202) 795–7714. FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting information, please include the document identifier 0990–New–60D and project title for reference, to Sherrette A. Funn, email: Sherrette.Funn@hhs.gov, or call (202) SUMMARY: 795–7714, the Reports Clearance Officer. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Title of the Collection: Research Complaint Form. Type of Collection: New. OMB No.: 0990-New. Abstract: The Office of the Assistant Secretary for Health, Office for Human Research Protections (OHRP), is requesting a new approval from the Office of Management and Budget of OHRP’s Research Complaint Form. This form will provide a simplified standardized format for submitting to OHRP allegations of noncompliance involving human subject research conducted or supported by HHS. The information collected will help OHRP ensure the rights of human subjects involved in such research and that OHRP-assured institutions are complying with the HHS Protection of Human Subjects regulations. SUPPLEMENTARY INFORMATION: ANNUALIZED BURDEN HOUR TABLE Number of respondents Form name Average burden per response (in hours) Total burden hours Research Complaint Form ............................................................................... Research Complaint Form ............................................................................... Research Complaint Form ............................................................................... 500 400 100 1 2 3 30/60 30/60 30/60 250 400 150 Total .......................................................................................................... ........................ ........................ ........................ 800 Sherrette A. Funn, Paperwork Reduction Act Reports Clearance Officer, Office of the Secretary. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2022–27028 Filed 12–12–22; 8:45 am] National Institutes of Health BILLING CODE 4150–36–P lotter on DSK11XQN23PROD with NOTICES1 Number of responses per respondent National Center for Advancing Translational Sciences; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Center for Advancing Translational Sciences Advisory Council. VerDate Sep<11>2014 16:56 Dec 12, 2022 Jkt 259001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 This meeting is being held virtually only; there is no in-person option. The open session will be videocast and may be accessed by the public from the NIH Videocasting and Podcasting website (https://videocast.nih.gov). Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., E:\FR\FM\13DEN1.SGM 13DEN1 Federal Register / Vol. 87, No. 238 / Tuesday, December 13, 2022 / Notices as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Advisory Council. Date: January 26, 2023. Closed: 11:00 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza 9th Floor, Room 987/989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Open: 1:00 p.m. to 6:00 p.m. Agenda: Report from the Institute Director, Invited Speaker presentation, Office of Special Initiates (OSI) and Office of Strategic Alliances (OSA) Program Updates. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, 9th Floor, Room 987/989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301–435–0809, anna.ramseyewing@ nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice no later than 15 days after the meeting at NCATSCouncilInput@ mail.nih.gov. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: December 7, 2022. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–26992 Filed 12–12–22; 8:45 am] BILLING CODE 4140–01–P lotter on DSK11XQN23PROD with NOTICES1 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a VerDate Sep<11>2014 17:48 Dec 12, 2022 Jkt 259001 76207 meeting of the Sickle Cell Disease Advisory Committee. The meeting will be open to the public through a virtual meeting. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: Sickle Cell Disease Advisory Committee. Date: January 30, 2023. Time: 10:00 a.m. to 2:30 p.m. Agenda: Research, engagement and representation from the community. Place: National Institutes of Health, Rockledge 1, 6705 Rockledge Dr, Bethesda, MD 20892, (Virtual Meeting—Teleconference andZoomGov). Telephone Access: +1 669 254 5252 (Meeting ID 160 763 2658). Virtual Access: https://nih.zoomgov.com/j/ 1607632658, (Meeting ID: 160 763 2658). Contact Person: Nahed El Kassar, MD, Ph.D. Medical Officer National Heart, Lung, and Blood Institute, Blood Epidemiology & Clinical Therapeutics Branch, Division of Blood Diseases and Resources, 6701 Rockledge Drive, Suite 9166, Bethesda, MD 20892, 301–435–0080, NHLBIDBDRGrantResource@nhlbi.nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) HHS. Dated: December 8, 2022. David W Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–26996 Filed 12–12–22; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 National Institutes of Health Request for Information (RFI) on Proposed Simplified Review Framework for NIH Research Project Grant Applications; Correction AGENCY: National Institutes of Health, Request for information; correction. ACTION: The Department of Health and Human Services, National Institutes of Health published a Notice in the Federal Register on December 7, 2022. That Notice requires a correction in the SUPPLEMENTARY INFORMATION section. FOR FURTHER INFORMATION CONTACT: Questions about this request for information should be directed to Office of Extramural Research, Dr. Kristin Kramer, Phone number (301) 437–0911, Email simplifiedreview@nih.gov. SUPPLEMENTARY INFORMATION: SUMMARY: Correction In the Federal Register of December 7, 2022 in FR Doc. 2022–26603, on pages 75056–75057, as found within the SUPPLEMENTARY INFORMATION section, which provides reference URLs to the following: Proposal Development March 2021 slides; currently reads https://public.csr.nih.gov/sites//files/ 2021-04/Simplifying_Review_Criteria_ 29_March_2021.pdf and is corrected to read https://public.csr.nih.gov/sites/ default/files/2021-04/Simplifying_ Review_Criteria_29_March_2021.pdf. Final recommendations from the CSR Advisory Council report; currently reads https://public.csr.nih.gov/sitest/files/ 2021-04/Recommendations_of_the_ CSRAC_Working_Group_on_ Simplifying_Review-non-CT_and_ CT.pdf and is corrected to read https:// public.csr.nih.gov/sites/default/files/ 2021-04/Recommendations_of_the_ CSRAC_Working_Group_on_ Simplifying_Review-non-CT_and_ CT.pdf. Additional background information can be found here; currently reads https://grants.nih.gov/policyroposedFramework/index.htm and is corrected to read https://grants.nih.gov/policy/ peer/Proposed-Framework/index.htm Proposed Revised Simplified Review Framework Detailed descriptions of the three factors can be found here; currently reads https://grants.nih.gov/ E:\FR\FM\13DEN1.SGM 13DEN1

Agencies

[Federal Register Volume 87, Number 238 (Tuesday, December 13, 2022)]
[Notices]
[Pages 76206-76207]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26992]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Center for 
Advancing Translational Sciences Advisory Council.
    This meeting is being held virtually only; there is no in-person 
option. The open session will be videocast and may be accessed by the 
public from the NIH Videocasting and Podcasting website (https://videocast.nih.gov). Individuals who need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C.,

[[Page 76207]]

as amended. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Advisory Council.
    Date: January 26, 2023.
    Closed: 11:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza 9th Floor, Room 
987/989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Open: 1:00 p.m. to 6:00 p.m.
    Agenda: Report from the Institute Director, Invited Speaker 
presentation, Office of Special Initiates (OSI) and Office of 
Strategic Alliances (OSA) Program Updates.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, 9th Floor, Room 
987/989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive 
Secretary, National Center for Advancing Translational Sciences, 1 
Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice no later than 15 days after the meeting at 
[email protected]. The statement should include the 
name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: December 7, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-26992 Filed 12-12-22; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.